BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08046033 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08046033\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07519655-7696@assetmemo.bio
DTSTAMP:20261121T005342Z
DTSTART;VALUE=DATE:20280714
DTEND;VALUE=DATE:20280715
SUMMARY:PF-08046033: Phase 1 readout est. (NCT07519655)
DESCRIPTION:PF-08046033\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Pha
 se 1 Study of PF-08046033 in Advanced Solid Tumors\nEstimated primary comp
 letion: 14 July 2028. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /pf-08046033#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07519655
URL:https://assetmemo.bio/drug/pf-08046033#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
